Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Other Routine +

Nevis Brands Inc. Announces Expansion into the Functional Wellness Market with the Launch of OOMRA Adaptogen and Nootropic Beverages

Diversification into Non-THC Wellness Amidst Regulatory Overhang and Price Erosion

By The Northwire Desk — AI Analysis May 13, 2026 · 10:01 NEVI · 0.03 Nevis Brands Inc.
Executive Summary
  • Product Launch: Nevis Brands Inc. announced the launch of OOMRA™, a line of non-psychoactive adaptogen beverages (CLARITY and UNWIND formulations).
  • Strategic Pivot: The move diversifies revenue streams away from cannabis/hemp-derived THC products into the mainstream functional wellness market.
  • Revenue Timeline: Management expects OOMRA to begin contributing to revenues in Q3 2026.
  • Distribution: Currently Direct-to-Consumer (DTC) with discussions ongoing for convenience store placement.
  • Context: This follows a fiscal year where the company achieved positive operating cash flow ($62,102) and narrowed its operational loss to near break-even levels ($18,716 adjusted).
Material Impact
  • Market Reaction Divergence: Despite previous positive earnings in March 2026 (positive operating cash flow), the stock price has declined from $0.09 in October 2025 to $0.03 in May 2026. This indicates skepticism regarding the sustainability of growth or regulatory risks outweighing operational improvements.
  • Regulatory Risk Mitigation: The Dec 2025 news highlighted a federal government announcement ending the sale of Hemp Derived THC in late 2026. OOMRA is non-psychoactive, which mitigates this specific risk, but it does not eliminate the core business exposure immediately as revenue contribution starts Q3 2026.
  • Incremental Growth: The launch is consistent with previous expansion strategies (Major in NM/AZ, Happy Apple in Ohio). It lacks the "unexpected" nature required for a Material - Positive rating given the market's prior rejection of positive earnings news.
  • Capital Efficiency: While operating cash flow turned positive ($62k), scaling OOMRA will likely require additional capital or reinvestment, potentially straining liquidity before Q3 revenue materializes.
NEVI · Price
Company Overview
  • Core Business: Manufacturer and distributor of cannabis-infused beverages (Major™) and hemp-derived THC beverages (Happy Apple™).
  • Flagship Project: Major™ brand has sold over 5 million bottles since 2019 launch in Washington State.
  • Expansion Strategy: Multi-state growth into Illinois, New Mexico, Arizona, Ohio, New Jersey, Missouri, Wisconsin, and the Carolinas.
  • New Initiative: OOMRA™ functional wellness beverages (Adaptogens/Nootropics) designed to be alcohol-free and caffeine-free.
Read the original news release →

More from Nevis Brands Inc.

Mar 18, 2026 · 16:50

Nevis Brands Inc. Announces Fiscal 2025 Financial Results: Achieves Positive Operating Cash Flow And Double-Digit Q4 Revenue Growth

Earnings Dec 17, 2025 · 09:01

NEVIS BRANDS INC. Announces Corporate Update

Production / Operations Oct 30, 2025 · 08:15

Nevis Brands Announces Major(TM) Expansion

Production / Operations Oct 22, 2025 · 09:20

Nevis Brands Reports Q3 2025 Results: Quarterly Revenue Growth of 16% Amid Expanding Markets

Earnings Oct 22, 2025 · 03:06

SEDAR Interim Financial Statements

None